NMX Exercise Study
New Medtronic Automated Insulin Delivery Systems and Exercise for Adults with Type 1 Diabetes
Purpose
We are inviting people living with type 1 diabetes who are currently using the Medtronic MiniMed™ 780G insulin pump to take part in research exploring new insulin pump technology and exercise.
The study is investigating the effectiveness of the new automated insulin pump systems (NMX7 and NMX8) together with the Simplera Sync™ glucose sensor while exercising.
Who can take part?
You may be eligible to participate if you are:
- Aged 18 years or older
- Have been living with type 1 diabetes for at least 1 year
- Have an HbA1c less than 10%
- Currently on the Medtronic MiniMed™ 780G insulin pump, and have been for at least 3 months
What does participation involve?
This study requires your participation for up to 6 months and includes:
- At least 10 clinic visits at the clinical site, including 8 supervised exercise sessions
- Additional remote activities from home
During the study, you will need to take part in supervised exercise sessions, provide blood samples, receive health and diabetes assessments, use diabetes technology devices and upload data from home, apply glucose sensors and complete preparation activities at home all with regular remote support.
Reimbursement
There are no additional costs to you as a participant in the study.
You will be reimbursed a maximum of $900 in total if you complete all study activities.
Site Locations
- St Vincent’s Public Hospital, Melbourne
- Baker Diabetes and Heart Institute, Melbourne
Contact
Diabetes Technology Research Group Melbourne via email dtrg-t1research@unimelb.edu.au or call on 03 9231 2757.
This study has received ethical approval from the St Vincent’s Hospital Melbourne (Public) Human Research Ethics Committee ref# 263/25.